Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - Perspective Therapeutics, Inc. | StockGist | StockGist

Companies
CATX
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings CATXSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

Perspective Therapeutics, Inc.

Filed Nov 7, 2025

Accepted Nov 6, 2025, 7:00 PM ET

CIK 0000728387

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

% of Class

49.00%

Shares Owned

315,066

Reporting Person

Perspective Therapeutics, Inc.

Person Type

HC

CUSIP: 46489V302

Amendment History

6 filings

SCHEDULE 13G
Original
Feb 9, 20260001831942-26-000003
SCHEDULE 13G/A
Amendment 1
Feb 5, 20240001991777-24-000001
SCHEDULE 13G/A
Amendment 2
Feb 14, 20250000919574-25-001388
SCHEDULE 13G/A
Amendment 3
Feb 14, 20250001274173-25-000052
SCHEDULE 13G/A
Amendment 4
Viewing
Nov 7, 20250000315066-25-002922
SCHEDULE 13G/A
Amendment 5
Latest
Dec 5, 20250000315066-25-002958

Key Facts

% of Class

49.00%

Shares Owned

315,066

Recent Filings

Perspective Therapeutics, Inc.5 days ago

Perspective Therapeutics, Inc.1 months ago

Perspective Therapeutics, Inc.1 months ago

Perspective Therapeutics, Inc.1 months ago

Perspective Therapeutics, Inc.2 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice